03 enero 2021

Australia . $10 Million For High Potential COVID-19 Related Clinical Trials .


Project

Recipient

Funding

Prevention of SARS-CoV-2 transmission in aged care (PreSTAC): Effective evidence-based measures for rapid translation using ultraviolet light

Prof Geraint Rogers, South Australian Health and Medical Research Institute Limited

$1,366,094

Accelerated phase I trial of targeted and tunable SARS-Cov-2 spike protein receptor binding domain recombinant protein and mRNA vaccines

Prof Terry Nolan, University of Melbourne

$1,588,283

3D-Printed Facial Guards to reduce P2/N95 respirator leak and protect health care workers from COVID-19

Assoc Prof Anand Ganesan, Flinders University

$973,119

Statin Treatment for COVID-19 to optimise Neurological Recovery (STRONGER) trial – using Statins to prevent brain complications as a result of COVID-19

Prof Craig Anderson, University of New South Wales

$2,375,779

Use of Cardioprotective Therapy to Manage Persistent Cardiovascular Effects of COVID-19: A Pathway to Recognition and Treatment of Subclinical Disease

Prof Thomas Marwick, University of Melbourne

$2,574,943

The Pomerium Trial: Protecting Aged Care Residents from the Pandemic via Specialised Nutritional Supplementation.

Prof Gustavo Duque, University of Melbourne

$1,189,527

Total

 

$10,067,745